
Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.
Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.
Scientists have mapped the structure of a hepatitis C virus surface protein that is responsible for binding to host liver cells, leading to virus entry.
Saliva tests for detecting HCV infection may not be the best option for determining infection status.
During experiments with cell-to-cell and cell-free transmissions, researchers showed that existing drugs are effective in suppressing the spread of HIV.
Noting successful HIV/AIDS prevention efforts rely on early diagnosis, an analysis estimates that improved access to health insurance through the Affordable Care Act will increase the number of patients getting tested for HIV by nearly 500,000 over a 5-year period, though that impact would be amplified if all US states opted to expand Medicaid coverage.
Study results show hepatic decompensation is more common in people who have both HIV and hepatitis C virus (HCV) compared to those infected only with HCV, an indication that early HCV treatment among coinfected patients is needed.
Men with HIV have more noncalcified plaque in their arteries than their uninfected counterparts.